Joel Greenblatt acquired 66.4 Thousand Amedisys shares worth $6.1 Million. That's 0.11% of their equity portfolio (236th largest holding). The first Amedisys trade was made in Q4 2010. Since then Joel Greenblatt bought shares 21 more times and sold shares on seventeen occasions. The investor's estimated purchase price is $7.36 Million, resulting in a loss of 17%.